• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非洲南部肝细胞癌中p53基因的选择性G到T突变

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.

作者信息

Bressac B, Kew M, Wands J, Ozturk M

机构信息

Molecular Hepatology Laboratory, Massachusetts General Hospital Cancer Center, Charlestown 02129.

出版信息

Nature. 1991 Apr 4;350(6317):429-31. doi: 10.1038/350429a0.

DOI:10.1038/350429a0
PMID:1672732
Abstract

Hepatocellular carcinoma (HCC) is a prevalent cancer in sub-Saharan Africa and eastern Asia. Hepatitis B virus and aflatoxins are risk factors for HCC, but the molecular mechanism of human hepatocellular carcinogenesis is largely unknown. Abnormalities in the structure and expression of the tumour-suppressor gene p53 are frequent in HCC cell lines, and allelic losses from chromosome 17p have been found in HCCs from China and Japan. Here we report on allelic deletions from chromosome 17p and mutations of the p53 gene found in 50% of primary HCCs from southern Africa. Four of five mutations detected were G----T substitutions, with clustering at codon 249. This mutation specificity could reflect exposure to a specific carcinogen, one candidate being aflatoxin B1 (ref. 7), a food contaminant in Africa, which is both a mutagen that induces G to T substitution and a liver-specific carcinogen.

摘要

肝细胞癌(HCC)在撒哈拉以南非洲和东亚地区是一种常见癌症。乙型肝炎病毒和黄曲霉毒素是HCC的风险因素,但人类肝细胞癌发生的分子机制在很大程度上尚不清楚。肿瘤抑制基因p53的结构和表达异常在HCC细胞系中很常见,并且在中国和日本的HCC中已发现17号染色体短臂的等位基因缺失。在此,我们报告了在来自非洲南部的50%原发性HCC中发现的17号染色体短臂等位基因缺失和p53基因突变。检测到的5个突变中有4个是G→T替换,集中在密码子249处。这种突变特异性可能反映了对特定致癌物的暴露,一个候选物是黄曲霉毒素B1(参考文献7),它是非洲的一种食物污染物,既是一种诱导G到T替换的诱变剂,也是一种肝脏特异性致癌物。

相似文献

1
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.非洲南部肝细胞癌中p53基因的选择性G到T突变
Nature. 1991 Apr 4;350(6317):429-31. doi: 10.1038/350429a0.
2
Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.中国肝细胞癌中肿瘤抑制基因的改变及等位基因缺失
Cancer Res. 1994 Jan 1;54(1):281-5.
3
Mutational hotspot in the p53 gene in human hepatocellular carcinomas.人类肝细胞癌中p53基因的突变热点
Nature. 1991 Apr 4;350(6317):427-8. doi: 10.1038/350427a0.
4
Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.乙型肝炎病毒在靠近p53基因的人类17号染色体p臂上的整合事件,确定了在病毒阳性肝细胞癌中常见的染色体缺失区域。
Cancer Res. 1991 Jan 1;51(1):49-54.
5
p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.p53过表达在欧洲肝细胞癌中很常见,并且很大程度上独立于密码子249热点突变。
Oncogene. 1994 Jan;9(1):195-204.
6
Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.p53基因在肝细胞癌中的作用及突变异质性
Cancer Res. 1993 Jan 15;53(2):368-72.
7
TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.中国启东慢性乙型肝炎病毒携带者队列中TP53 R249S突变、黄曲霉毒素暴露与肝细胞癌发生情况
Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1638-43. doi: 10.1158/1055-9965.EPI-08-1102. Epub 2009 Apr 14.
8
Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.乙肝病毒阳性原发性肝细胞癌中p53基因的罕见突变
Oncogene. 1993 Feb;8(2):491-6.
9
State of the p53 gene in hepatocellular carcinomas of ground squirrels and woodchucks with past and ongoing infection with hepadnaviruses.过去和目前感染嗜肝DNA病毒的地松鼠和土拨鼠肝细胞癌中p53基因的状态
Cancer Res. 1994 Oct 15;54(20):5430-7.
10
p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.香港华人肝细胞癌中p53基因突变谱
Oncogene. 1994 Mar;9(3):985-90.

引用本文的文献

1
Cooperation Between Aflatoxin-Induced p53 Aberrations and Hepatitis B Virus in Hepatocellular Carcinoma.黄曲霉毒素诱导的p53畸变与乙型肝炎病毒在肝细胞癌中的协同作用。
J Xenobiot. 2025 Jun 20;15(4):96. doi: 10.3390/jox15040096.
2
Traditional Chinese Medicine as a Tool for the Treatment of Hepatocellular Carcinoma by Targeting Pathophysiological Mechanism.以病理生理机制为靶点治疗肝细胞癌的中医药手段
Cancer Manag Res. 2025 Apr 8;17:779-792. doi: 10.2147/CMAR.S513729. eCollection 2025.
3
Structurally Similar Mycotoxins Aflatoxin B and Sterigmatocystin Trigger Different and Distinctive High-Resolution Mutational Spectra in Mammalian Cells.
结构相似的霉菌毒素黄曲霉毒素B和柄曲霉素在哺乳动物细胞中引发不同且独特的高分辨率突变谱。
Toxins (Basel). 2025 Feb 27;17(3):112. doi: 10.3390/toxins17030112.
4
OTUD7B is a new deubiquitinase targeting p53.OTUD7B是一种靶向p53的新型去泛素化酶。
Theranostics. 2025 Jan 13;15(6):2121-2138. doi: 10.7150/thno.103012. eCollection 2025.
5
Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights.解读微小RNA在肝细胞癌中的多方面作用:整合文献综述与生物信息学分析以获取治疗见解
Heliyon. 2024 Oct 18;10(20):e39489. doi: 10.1016/j.heliyon.2024.e39489. eCollection 2024 Oct 30.
6
EFNA5 suppresses cell proliferation and tumor metastasis in hepatoma via epithelial-to-mesenchymal transition.EFNA5通过上皮-间质转化抑制肝癌细胞的增殖和肿瘤转移。
Discov Oncol. 2024 Oct 19;15(1):572. doi: 10.1007/s12672-024-01454-7.
7
Nucleotide excision repair of aflatoxin-induced DNA damage within the 3D human genome organization.在 3D 人类基因组结构中修复黄曲霉毒素诱导的 DNA 损伤的核苷酸切除修复。
Nucleic Acids Res. 2024 Oct 28;52(19):11704-11719. doi: 10.1093/nar/gkae755.
8
Comparative Proteomic Analysis of Huh7 Cells Transfected with Sub-Saharan African Hepatitis B Virus (Sub)genotypes Reveals Potential Oncogenic Factors.撒哈拉以南非洲乙型肝炎病毒(亚)基因型转染 Huh7 细胞的比较蛋白质组学分析揭示潜在的致癌因素。
Viruses. 2024 Jun 29;16(7):1052. doi: 10.3390/v16071052.
9
Current and Emerging Molecular Markers of Liver Diseases: A Pathogenic Perspective.肝脏疾病的当前及新出现的分子标志物:致病机制视角
Gene Expr. 2022;21(1):9-19. doi: 10.14218/gejlr.2022.00010. Epub 2022 Sep 28.
10
A history of the treatment of primary liver cancer.原发性肝癌的治疗史。
Clin Liver Dis (Hoboken). 2024 May 3;23(1):e0147. doi: 10.1097/CLD.0000000000000147. eCollection 2024 Jan-Jun.